| 1. |
Goldsmith H, Wells A, Sá MJN, et al. Expanding the phenotype of intellectual disability caused by HIVEP2 variants. American Journal of Medical Genetics (Part A), 2019, 179(9): 1872-1877.
|
| 2. |
Park J, Colombo R, Sch?ferhoff K, et al. Novel HIVEP2 variants in patients with intellectual disability. Molecular Syndromology, 2019, 10(4): 195-201.
|
| 3. |
Steinfeld H, Cho MT, Retterer K, et al. Mutations in HIVEP2 are associated with developmental delay, intellectual disability, and dysmorphic features. Neurogenetics, 2016, 17(3): 159-164.
|
| 4. |
王新平, 段鵬, 鄧杰, 等. CHD2 基因合并 HIVEP2 基因新變異導致智力障礙伴癲癇性腦病家系遺傳分析. 中國優生與遺傳雜志, 2023, 32: 1254-1261.
|
| 5. |
王星辰, 王婷, 王新宇, 等. 同時存在GNAS基因雜合錯義突變和HIVEP2基因新生突變的假性甲狀旁腺功能減退癥共患癲癇一例. 癲癇雜志, 2022, 8(2): 170-173.
|
| 6. |
Abreu M, Branco T, Figueiroa S, et al. Parental gonadossomatic mosaicism in HIVEP2-related intellectual disability and impact on genetic counseling-case report. Frontiers in Genetics, 2023, 14: 1156847.
|
| 7. |
Miyamoto S, Kato M, Hiraide T, et al. Comprehensive genetic analysis confers high diagnostic yield in 16 Japanese patients with corpus callosum anomalies. Journal of Human Genetics, 2021, 66(11): 1061-1068.
|
| 8. |
Quental R, Borges JP, Santos H, et al. Expanding the phenotypic spectrum of HIVEP2-related intellectual disability: description of two portuguese patients and review of the literature. Molecular Syndromology, 2022, 13(5): 397-401.
|
| 9. |
Srivastava S, Engels H, Schanze I, et al. Loss-of-function variants in HIVEP2 are a cause of intellectual disability. European Journal of Human Genetics, 2016, 24(4): 556-561.
|
| 10. |
Jain A, Atwal PS. Novel HIVEP2 variant p.Q1248* is associated with developmental delay: a case report. Journal of Pediatric Genetics, 2019, 8(3): 157-159.
|
| 11. |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 2015, 17(5): 405-424.
|
| 12. |
Zhao J, Chen C, Bell RL, et al. Identification of HIVEP2 as a dopaminergic transcription factor related to substance use disorders in rats and humans. Translational Psychiatry, 2019, 9(1): 247.
|
| 13. |
Mo A, Snyder LG, Babington O, et al. Neurodevelopmental profile of HIVEP2-related disorder. Developmental Medicine and Child Neurology, 2022, 64(5): 654-661.
|
| 14. |
Takao K, Kobayashi K, Hagihara H, et al. Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology, 2013, 38(8): 1409-1425.
|
| 15. |
Takagi T, Jin W, Taya K, et al. Schnurri-2 mutant mice are hypersensitive to stress and hyperactive. Brain Research, 2006, 1108(1): 88-97.
|
